Characterization of cyanide-trapped methylated metabonates formed during reactive drug metabolite screening in vitro

Rapid Communications in Mass Spectrometry

Volumn 25, Issue 10, 2011, Pages 1382-1390

  Rousu, Timo ^a,b   Tolonen, Ari ^a,c  

^a UNIVERSITY OF OULU   (Finland)

^b Novamass Analytical Ltd   (Finland)

^c Admescope Ltd   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION; ASSAYS; BIOMOLECULES; CYANIDES; DRUG PRODUCTS; LIQUID CHROMATOGRAPHY; METABOLISM; METABOLITES; METHYLATION; REACTION PRODUCTS; TRAPPED IONS;

CELL PROTEINS; CHEMICAL TRAPPING; DRUG METABOLITES; GLUTHATHIONE; HIGH REACTIVITY; IN-VITRO; LIFESPANS; METABOLITE SCREENING; REACTIVE METABOLITES; TRAPPED PRODUCTS;

MASS SPECTROMETRY;

EID: 79955076864     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.5005     Document Type: Article

References (33)

1. O. Pelkonen, M. Turpeinen, J. Uusitalo, A. Rautio, H. Raunio,. Prediction of drug metabolism and interactions on the basis of in vitro investigations. Basic Clin. Pharmacol. Toxicol. 2005, 96, 67.
2. S. Coecke, H. Ahr, B. J. Blaauboer, S. Bremer, S. Casati, J. Castell, R. Combes, R. Corvi, C. L. Crespi, M. L. Cunningham, G. Elaut, B. Eletti, A. Freidig, A. Gennari, J. F. Ghersi-Egea, A. Guillouzo, T. Hartung, P. Hoet, M. Ingelman-Sundberg, S. Munn, W. Janssens, B. Ladstetter, D. Leahy, A. Long, A. Meneguz, M. Monshouwer, S. Morath, F. Nagelkerke, O. Pelkonen, J. Ponti, P. Prieto, L. Richert, E. Sabbioni, B. Schaack, W. Steiling, E. Testai, J.A. Vericat, A. Worth,. Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM Workshop 54. Altern. Lab. Anim. 2006, 34, 49.
3. D. C. Evans, A. P. Watt, D. A. Nicoll-Griffith, T. A. Baillie,. Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem. Res. Toxicol. 2004, 17, 3.
4. F. P. Guengerich,. Principles of covalent binding of reactive metabolites and examples of activation of bis-electrophiles by conjugation. Arch. Biochem. Biophys. 2005, 433, 369.
5. T. A. Baillie,. Future of toxicology-metabolic activation and drug design: challenges and opportunities in chemical toxicology. Chem. Res. Toxicol. 2006, 19, 889.
6. J. L. Stevens,. Future of toxicology - mechanisms of toxicity and drug safety: where do we go from here? Chem. Res. Toxicol. 2006, 19, 1393.
7. F. P. Guengerich, J. S. MacDonald,. Applying mechanisms of chemical toxicity to predict drug safety. Chem. Res. Toxicol. 2007, 20, 344.
8. D. P. Williams, N. R. Kintteringham, D. J. Naisbitt, M. Pirmohamed, D. A. Smith, B. Park, Are chemically reactive metabolites responsible for adverse reactions to drugs? Curr. Drug Metab. 2002, 3, 351.
9. R. A. Roth, J. P. Luyendyk, J. F. Maddox, P. E. Ganey,. Inflammation and drug idiosyncrasy - is there a connection? J. Pharmacol. Exp. Ther. 2003, 307, 1.
10. S. Ma, R. Subramanian,. Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry. J. Mass Spectrom. 2006, 41, 1121.
11. C. M. Dieckhaus, C. L. Fernandez-Metzler, R. King, P. H. Krolikowski, T. A. Baillie,. Negative ion tandem mass spectrometry for the detection of glutathione conjugates. Chem. Res. Toxicol. 2005, 18, 630.
12. Z. Yan, G. W. Caldwell,. Stable-isotope trapping and high-throughput screenings of reactive metabolites using the isotope MS signature. Anal. Chem. 2004, 76, 6835.
13. Z. Yan, N. Maher, R. Torres, G. W. Caldwell, N. Huebert,. Rapid detection and characterization of minor reactive metabolites using stable-isotope trapping in combination with tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2005, 19, 3322.
14. A. Mutlib, W. Lam, J. Atherton, H. Chen, P. Galatsis, W. Stolle,. Application of stable isotope labeled glutathione and rapid scanning mass spectrometers in detecting and characterizing reactive metabolites. Rapid Commun. Mass Spectrom. 2005, 19, 3482.
15. J. Zheng, L. Ma, B. Xin, T. Olah, W. G. Humphreys, M. Zhu,. Screening and identification of GSH-trapped reactive metabolites using hybrid triple quadruple linear ion trap mass spectrometry. Chem. Res. Toxicol. 2007, 20, 757.
16. B. Wen, L. Ma, S. D. Nelson, M. Zhu,. High-throughput screening and characterization of reactive metabolites using polarity switching of hybrid triple quadrupole linear ion trap mass spectrometry. Anal. Chem. 2008, 80, 1788.
17. J. Castro-Perez, R. Plumb, L. Liang, E. Yang,. A high-throughput liquid chromatography/tandem mass spectrometry method for screening glutathione conjugates using exact mass neutral loss acquisition. Rapid Commun. Mass Spectrom. 2005, 19, 798.
18. M. Zhu, L. Ma, H. Zhang, W. G. Humphreys,. Detection and structural characterization of glutathione-trapped reactive metabolites using liquid chromatography-high-resolution mass spectrometry and mass defect filtering. Anal. Chem. 2007, 79, 8333.
19. A. LeBlanck, T. C. Shiao, R. Roy, L. Sleno,. Improved detection of reactive metabolites with a bromine-containing glutathione analog using mass defect and isotope pattern matching. Rapid Commun. Mass Spectrom. 2010, 24, 1241.
20. T. Rousu, O. Pelkonen, A. Tolonen,. Rapid detection and characterization of reactive drug metabolites in vitro using several isotope-labeled trapping agents and ultra-performance liquid chromatography/time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2009, 23, 843.
21. G. Meneses-Lorente, M. Z. Sakatis, T. Schulz-Utermoehl, C. De Nardi, A. P. Watt,. A quantitative high-throughput trapping assay as a measurement of potential for bioactivation. Anal. Biochem. 2006, 351, 266.
22. D. Argoti, L. Liang, A. Conteh, L. Chen, D. Bershas, C. P. Yu, P. Vouros, E. Yang,. Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Chem. Res. Toxicol. 2005, 18, 1537.
23. C. Li, S. Surapaneni, Q. Zeng, B. Marquez, D. Chow, G. Kumar,. Identification of a novel in vitro metabonate from liver microsomal incubations. Drug Metab. Dispos. 2006, 34, 901.
24. J. E. Barbara, F. Kazmi, P. C. Toren, A. Parinson,. Accurate mass spectrometry elucidates a misleading metabonate formed from amine-containing drugs in reactive metabolite screening assays. Poster LB43 at the 9th International ISSX Meeting, Istanbul, Turkey, September 2010. Drug Met. Rev. 2010, 42, Supplement 1.
25. A. H. Beckett,. Metabolic oxidation of aliphatic basic nitrogen atoms and their alpha-carbon atoms. Xenobiotica 1971, 1, 365.
26. A. L. Upthagrove, M. Hackett, W. L. Nelson,. Mass spectral fragmentation pathways of propranolol related beta-fluorinated amines studied by electrospray and electron impact ionization. Rapid Commun. Mass Spectrom. 1999, 13, 1671.
27. H. Kurebayashi, A. Tanaka, T. Yamaha,. Oxygen-18 studies on the oxidative deamination mechanism of alicyclic primary amines in rabbit liver microsomes. Arch. Biochem. Biophys. 1982, 215, 433.
28. M. Bertoldi, B. Cellini, R. Montioli, C. Borri Voltrattorni,. Insights into the mechanism of oxidative deamination catalyzed by DOPA decarboxylase. Biochemistry 2008, 47, 7187.
29. H. Kurebayashi, A. Tanaka, T. Yamaha, A. Tatahashi,. Oxidative deamination of alicyclic primary amines by liver microsomes from rats and rabbits. Xenobiotica 1988, 9, 1039.
30. J. Gibbons, J. Pugh, G. Dimoulos-Italiano, R. Pike,. A qualitative study of amlodipine and its related compounds by electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2006, 20, 1715.
31. B. Suchanova, R. Kostiainen, R. A. Ketola,. Characterization of the in vitro metabolic profile of amlodipine in rat using liquid chromatography-mass spectrometry. Eur. J. Pharm. Sci. 2009, 33, 91.
32. M. L. Bandu, H. Desaire,. The STEP method (statistical test of equivalent pathways): application to pharmaceuticals. Analyst 2006, 131, 268.
33. W. M. Awni, J. Clarkson, D. R. Guay,. Determination of ciprofloxacin and its 7-ethylenediamine metabolite in human serum and urine by high-performance liquid chromatography. J. Chromatogr. 1987, 419, 414.